• vitiligo pipeline 2026: therapies under investigation, clinical trials milestones, and fda approvals by delveinsight | dermira, am... Barchart.com Tue, 07 Jul 2026 22:22:19 GMT
• Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength? Yahoo Finance Wed, 01 Jul 2026 07:00:00 GMT
• Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:48:57 GMT
• Aclaris Therapeutics, Inc.(NasdaqGS: ACRS) added to Russell 3000E Growth Benchmark marketscreener.com Mon, 29 Jun 2026 04:16:39 GMT
• aclaris therapeutics, inc.(nasdaqgs: acrs) added to russell 3000 growth benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Price to sales forward of Aclaris Therapeutics, Inc. – NASDAQ:ACRS TradingView Sun, 28 Jun 2026 09:26:23 GMT
• Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Price to earnings forward of Aclaris Therapeutics, Inc. – DUS:8AT TradingView Sat, 27 Jun 2026 16:07:23 GMT
• enterprise value to ebitda forward of aclaris therapeutics, inc. – nasdaq:acrs TradingView Sat, 27 Jun 2026 03:59:36 GMT
• Aclaris Therapeutics, Inc. Actuals & Estimates (NASDAQ:ACRS) TradingView Fri, 26 Jun 2026 09:57:53 GMT
• We Think Aclaris Therapeutics (NASDAQ:ACRS) Can Afford To Drive Business Growth Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• aclaris therapeutics inc (acrs) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• aclaris therapeutics, inc.(nasdaqgs:acrs) added to s&p pharmaceuticals select industry index marketscreener.com Mon, 22 Jun 2026 01:27:30 GMT
• aclaris therapeutics inc (acrs) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 08:55:08 GMT
• aclaris therapeutics inc (acrs) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 01:24:39 GMT
• Aclaris Therapeutics Inc (ACRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 00:55:23 GMT
• aclaris therapeutics inc (acrs) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 18:21:19 GMT
• aclaris therapeutics inc (acrs) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 18:17:24 GMT
• aclaris therapeutics inc (acrs) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 17:55:08 GMT
• aclaris therapeutics inc (acrs) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:54:56 GMT
• aclaris therapeutics inc (acrs) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 17:48:01 GMT
• aclaris therapeutics holds steady near support as biotech sector watches key levels - momentum factor newsline.com Wed, 17 Jun 2026 02:46:33 GMT
• aclaris therapeutics inc (acrs) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aclaris therapeutics inc (acrs) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aclaris therapeutics inc (acrs) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aclaris therapeutics (acrs) gains analyst attention as stifel flags penny stock opportunity - high estimate range newsline.com Tue, 09 Jun 2026 06:06:03 GMT
• aclaris (acrs) director andrew schiff reports rsu vesting and new stock option grant Stock Titan Mon, 08 Jun 2026 20:15:16 GMT
• aclaris therapeutics (acrs) director gains new rsus and stock options Stock Titan Mon, 08 Jun 2026 20:15:06 GMT
• Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• aclaris therapeutics maps busy pipeline calendar, plans phase 2 asthma trial for ati-052 MSN Sat, 06 Jun 2026 20:20:34 GMT
• shareholders at aclaris (nasdaq: acrs) back directors, executive pay and pwc Stock Titan Thu, 04 Jun 2026 20:01:13 GMT
• acrs: all proposals passed, with no stockholder questions submitted during the meeting TradingView Thu, 04 Jun 2026 13:24:16 GMT
• Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052 Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• aclaris therapeutics price target announced at $13.00/share by lifesci capital Moomoo Wed, 03 Jun 2026 10:04:54 GMT
• this piper sandler analyst begins coverage on a bullish note; here are top 3 initiations from tuesday Benzinga Wed, 03 Jun 2026 07:00:00 GMT
• acrs initiated coverage by lifesci capital -- rating 'outperform' GuruFocus Wed, 03 Jun 2026 03:45:00 GMT
• aclaris therapeutics price target announced at $13.00/share by lifesci capital Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• aclaris dips ahead of jefferies, with focus on 2026 trial data Bez Kabli Mon, 01 Jun 2026 20:29:48 GMT
• acrs q1 2026 earnings: smaller-than-expected loss as pre-revenue biotech advances pipeline - earnings acceleration picks newsline.com Fri, 29 May 2026 07:00:00 GMT
• aclaris therapeutics to participate in the 2026 jefferies global healthcare conference Yahoo Finance Thu, 28 May 2026 07:00:00 GMT
• Aclaris Therapeutics (ACRS) Edges Higher, Testing Key Resistance Near $4.81 - Wedge Breakout dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• aclaris therapeutics (acrs) gains 2.44% as buyers defend key support zone - regression channel newsline.com Wed, 27 May 2026 07:00:00 GMT
• aclaris therapeutics holds steady near mid-range as traders eye key support and resistance - mfi divergence newsline.com Tue, 26 May 2026 07:00:00 GMT
• Aclaris Therapeutics (ACRS) Holds Near Support as Volume Suggests Cautious Sentiment - OBV Breakout Město Břeclav Mon, 25 May 2026 07:00:00 GMT
• Aclaris Therapeutics, Inc. Stock 12‑Month Price Target Raised to $10.2, Implies 126% Upside TradingView Sat, 23 May 2026 07:00:00 GMT
• aclaris (acrs) q1 2026 beat: revenue $n/a, eps exceeds by significant - dividend growth analysis newsline.com Wed, 20 May 2026 07:00:00 GMT
• piper sandler maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $11 富途牛牛 Tue, 19 May 2026 11:33:34 GMT
• aclaris therapeutics (acrs) price target increased by 12.65% to 9.64 MSN Tue, 19 May 2026 03:25:40 GMT
• guggenheim maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $12 富途牛牛 Tue, 19 May 2026 01:27:41 GMT
• aclaris therapeutics, inc. - common stock (nq: acrs The Chronicle-Journal Mon, 18 May 2026 17:21:06 GMT
• aclaris therapeutics (acrs) price target increased by 12.65% to 9.64 MSN Sun, 17 May 2026 01:04:47 GMT
• aclaris expands immunology pipeline ahead of key trial data MyChesCo Sat, 16 May 2026 17:00:00 GMT
• aclaris therapeutics (acrs) price target increased by 12.65% to 9.64 MSN Fri, 15 May 2026 00:20:03 GMT
• acrs: multiple late-stage immunology assets advance toward key 2024 milestones, backed by robust funding TradingView Thu, 14 May 2026 17:25:49 GMT
• acrs: multiple innovative i&i therapies advance toward key phase 2b milestones in 2026 TradingView Thu, 14 May 2026 16:36:48 GMT
• aclaris therapeutics (acrs) reports q3 loss, tops revenue estimates MSN Tue, 12 May 2026 13:25:11 GMT
• aclaris therapeutics: advancing immunology pipeline and strong cash position support reiterated buy, unchanged $16 price target TipRanks Mon, 11 May 2026 17:41:13 GMT
• guggenheim maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $12 Moomoo Mon, 11 May 2026 12:31:00 GMT
• h.c. wainwright maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $16 富途牛牛 Mon, 11 May 2026 07:00:00 GMT
• piper sandler maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $11 Moomoo Mon, 11 May 2026 07:00:00 GMT
• wedbush maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $10 富途牛牛 Sun, 10 May 2026 09:29:24 GMT
• oppenheimer maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $10 富途牛牛 Sun, 10 May 2026 08:57:37 GMT
• oppenheimer maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $10 Moomoo Fri, 08 May 2026 13:31:00 GMT
• Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference Yahoo Finance Fri, 08 May 2026 07:00:00 GMT
• Aclaris Therapeutics (ACRS) Quarterly Loss Near US$20 Million Reinforces Bearish Earnings Narrative simplywall.st Fri, 08 May 2026 07:00:00 GMT
• stifel raises aclaris therapeutics price target to $4 on pipeline Investing.com Fri, 08 May 2026 07:00:00 GMT
• aclaris therapeutics (nasdaq: acrs) deepens loss while boosting r&d Stock Titan Thu, 07 May 2026 20:32:40 GMT
• aclaris therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Thu, 07 May 2026 13:18:37 GMT
• aclaris therapeutics | 8-k: aclaris therapeutics reports first quarter 2026 financial results and provides corporate and clinical ... Moomoo Thu, 07 May 2026 11:17:07 GMT
• aclaris (nasdaq: acrs) posts q1 2026 loss but boosts cash runway Stock Titan Thu, 07 May 2026 11:15:28 GMT
• Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• aclaris says cash lasts through 2028 with key skin, asthma data due Stock Titan Thu, 07 May 2026 07:00:00 GMT
• aclaris therapeutics (acrs) reports q1 loss, beats revenue estimates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• press release: aclaris therapeutics reports first quarter 2026 financial results and provides corporate and clinical update Moomoo Thu, 07 May 2026 07:00:00 GMT
• aclaris therapeutics (acrs) to release earnings on thursday MarketBeat Thu, 07 May 2026 07:00:00 GMT
• aclaris therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• craig-hallum maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $10 Moomoo Thu, 07 May 2026 07:00:00 GMT
• this applied materials analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Sahm Wed, 06 May 2026 14:51:11 GMT
• aclaris therapeutics is maintained at overweight by piper sandler Moomoo Wed, 06 May 2026 12:36:56 GMT
• guggenheim initiates coverage of aclaris therapeutics (acrs) with buy recommendation MSN Wed, 06 May 2026 10:59:06 GMT
• aclaris therapeutics (nasdaq:acrs) stock rating upgraded by guggenheim MarketBeat Wed, 06 May 2026 07:00:00 GMT
• aclaris (acrs) cmo vesting 36,375 rsus with 9,330 shares tax withheld Stock Titan Tue, 05 May 2026 20:15:15 GMT
• guggenheim initiates aclaris therapeutics(acrs.us) with buy rating, announces target price $12 Moomoo Tue, 05 May 2026 15:12:29 GMT
• aclaris reports phase 1a results for ati-052, advances pipeline MyChesCo Tue, 05 May 2026 12:12:02 GMT
• guggenheim initiates coverage of aclaris therapeutics (acrs) with buy recommendation MSN Tue, 05 May 2026 07:00:00 GMT
• this applied materials analyst begins coverage on a bullish note; here are top 5 initiations for tuesday Sahm Tue, 05 May 2026 07:00:00 GMT
• aclaris therapeutics is maintained at overweight by piper sandler Moomoo Tue, 05 May 2026 07:00:00 GMT
• piper sandler maintains aclaris therapeutics(acrs.us) with buy rating, raises target price to $11 Moomoo Tue, 05 May 2026 07:00:00 GMT
• aclaris therapeutics price target raised to $11 from $7 at piper sandler TipRanks Tue, 05 May 2026 07:00:00 GMT
• Companies Like Aclaris Therapeutics (NASDAQ:ACRS) Are In A Position To Invest In Growth Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• aclaris therapeutics inc expected to post a loss of 16 cents a share - earnings preview TradingView Mon, 04 May 2026 07:00:00 GMT
• guggenheim initiates aclaris therapeutics(acrs.us) with buy rating, announces target price $12 Moomoo Mon, 04 May 2026 07:00:00 GMT
• aclaris therapeutics, inc. (nasdaq:acrs) given consensus recommendation of "moderate buy" by analysts MarketBeat Sun, 03 May 2026 07:00:00 GMT
• Craig-Hallum Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $10 Moomoo Thu, 30 Apr 2026 07:00:00 GMT
• psoriasis market: investment-ready growth trends to 2034 – delveinsight | sun pharma, bristol-myers squibb, ucb biopharma, affibod... Barchart.com Wed, 29 Apr 2026 21:40:20 GMT
• aclaris therapeutics price target raised to $10 from $8 at wedbush TipRanks Wed, 29 Apr 2026 12:24:56 GMT
• h.c. wainwright maintains aclaris therapeutics(acrs.us) with buy rating, maintains target price $16 Moomoo Wed, 29 Apr 2026 07:00:00 GMT
• wedbush maintains aclaris therapeutics(acrs.us) with buy rating, raises target price to $10 Moomoo Wed, 29 Apr 2026 07:00:00 GMT
• aclaris posts strong phase 1a ati-052 data, sets lichen planus as lead indication for ati-2138 RTTNews Tue, 28 Apr 2026 11:56:00 GMT
• aclaris therapeutics announced that the phase 1b clinical trial of its drug candidate ati-052 is currently actively recruiting pat... Bitget Tue, 28 Apr 2026 10:48:53 GMT
• in the latest clinical trial data released by aclaris therapeutics (nasdaq: acrs), researchers found that the development of anti-... Bitget Tue, 28 Apr 2026 10:44:32 GMT
• Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI... GlobeNewswire Tue, 28 Apr 2026 07:00:00 GMT
• Aclaris Therapeutics Updates ATI-052 Phase 1 Data, Picks ATI-2138 for Phase 2b in Lichen Planus Yahoo Finance Tue, 28 Apr 2026 07:00:00 GMT
• Aclaris Reports Positive ATI-052 Topline Results; Sets Sights on Lichen Planus with ATI-2138 Dermatology Times Tue, 28 Apr 2026 07:00:00 GMT
• Aclaris reports phase 1a trial results for ATI-052 antibody Investing.com Tue, 28 Apr 2026 07:00:00 GMT
• aclaris therapeutics, inc. (acrs) discusses clinical program update and progress of lead bispecific antibody candidates - slidesho... Seeking Alpha Tue, 28 Apr 2026 07:00:00 GMT
• aclaris targets lichen planus, a disease with no approved therapies Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• aclaris therapeutics to provide clinical update on key biologic and oral inhibitor programs on april 28, 2026 Investing News Network Tue, 28 Apr 2026 07:00:00 GMT
• aclaris (nasdaq: acrs) touts ati-052 data, targets lichen planus with ati-2138 Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• aclaris therapeutics says positive full top line results from phase 1a clinical trial of ati-055 marketscreener.com Tue, 28 Apr 2026 07:00:00 GMT
• aclaris therapeutics insider sold shares worth $1,359,000, according to a recent sec filing marketscreener.com Tue, 28 Apr 2026 07:00:00 GMT
• aclaris therapeutics’ ati-052 antibody shows pk efficacy in phase 1a trial TipRanks Tue, 28 Apr 2026 07:00:00 GMT
• major aclaris insider makes bold move with large stock sale TipRanks Tue, 28 Apr 2026 02:54:07 GMT
• aclaris therapeutics (nasdaq:acrs) major shareholder braden michael leonard sells 300,000 shares MarketBeat Tue, 28 Apr 2026 00:19:33 GMT
• leonard braden michael sells $1.36m in aclaris therapeutics stock by investing.com Investing.com Australia Tue, 28 Apr 2026 00:05:49 GMT
• aclaris therapeutics announced that the phase 1b clinical trial of its drug candidate ati-052 is currently actively recruiting pat... Exchange Bitget Mon, 27 Apr 2026 19:38:12 GMT
• in the latest clinical trial data released by aclaris therapeutics (nasdaq: acrs), researchers found that the development of anti-... Bitget Mon, 27 Apr 2026 19:38:04 GMT
• aclaris therapeutics (acrs) piper sandler 36th annual healthcare conference summary Quartr Mon, 27 Apr 2026 17:52:07 GMT
• Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026 GlobeNewswire Mon, 27 Apr 2026 07:00:00 GMT
• what aclaris will reveal tuesday on two immune-disease drug programs Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• leonard braden michael sells $1.36m in aclaris therapeutics stock Investing.com Mon, 27 Apr 2026 07:00:00 GMT
• aclaris therapeutics | 4: statement of changes in beneficial ownership of securities-10% owner leonard braden michael - moomoo Moomoo Mon, 27 Apr 2026 07:00:00 GMT
• aclaris therapeutics to announce phase 1a trial results for ati-052 and lead indication selection for ati-2138 on april 28, 2026 Quiver Quantitative Mon, 27 Apr 2026 07:00:00 GMT
• bml investment lists 13.95m shares (9.9%) in aclaris (nasdaq: acrs) Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• aclaris to release ati-052 trial data, ati-2138 update tuesday by investing.com Investing.com Canada Mon, 27 Apr 2026 07:00:00 GMT
• biopharmaceutical company aclaris therapeutics announced plans to release updated clinical data for its key biologics and oral inh... Bitget Mon, 27 Apr 2026 07:00:00 GMT
• aclaris therapeutics (nasdaq: acrs) insider-linked fund sells 300,000 shares Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• major aclaris insider makes bold move with large stock sale TipRanks Mon, 27 Apr 2026 07:00:00 GMT
• aclaris therapeutics (nasdaq:acrs) shares gap down - here's what happened MarketBeat Fri, 24 Apr 2026 17:36:48 GMT
• Aclaris Therapeutics, Inc. ($ACRS) CEO 2025 Pay Revealed Quiver Quantitative Thu, 23 Apr 2026 07:00:00 GMT
Aclaris Therapeutics, Inc(NASDAQ:ACRS) 
Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational or...
Website: http://www.aclaristx.com
Founded: 2012
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology